Patients are increasingly turning to AI, social media and online searches for information about their health and medications, ...
Investigational oral interleukin-23 inhibitor icotrokinra sustained efficacy and favorable tolerability through week 76 in ...
The FDA has approved the Zilbrysq autoinjector, a macrocyclic peptide C5 inhibitor and the first such administration option ...
A new retrospective cohort study revealed that more than half of early childhood exposures to hepatitis B virus come from ...
Children were twice as likely to begin and complete the HPV vaccine series at clinics that began recommending it at ages 9 ...
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a recent cover story examining how the practice of rheumatology has changed across ...
Costs associated with antimicrobial resistance neared $1 trillion in 2021, according to data presented at IDWeek. Hardik ...
Among patients with bronchiectasis, those with purulent vs. mucoid or mucopurulent sputum had higher measures of neutrophil ...
Children wearing Essilor Stellest 2.0 lenses for 6 months had reductions in myopia progression comparable to changes in children who wore the original version of the glasses for a year, according to a ...
Alcon has acquired Neurotech Pharmaceuticals and Encelto, its macular telangiectasia type 2 therapy, according to a press release.Alcon paid $550 million in the acquisition of Neurotech and could make ...
Antidrug antibodies did not appear to negatively affect outcomes in patients with inflammatory bowel disease after initiation of subcutaneous infliximab following a “drug holiday,” according to a ...
The FDA approved bepirovirsen as the first antisense oligonucleotide for chronic hepatitis B virus infection, alongside existing antiviral therapy for eligible adults without cirrhosis. Bepirovirsen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results